No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic

被引：36

作者：

Schwaiger, Julia ^{[1
]}

Karbiener, Michael ^{[1
]}

Aberham, Claudia ^{[2
]}

Farcet, Maria R. ^{[1
]}

Kreil, Thomas R. ^{[1
]}

机构：

[1] Baxter AG, Global Pathogen Safety, Vienna, Austria

[2] Baxter AG, BioLife, Vienna, Austria

来源：

JOURNAL OF INFECTIOUS DISEASES | 2020年 / 222卷 / 12期

关键词：

primary immunodeficiency; SARS-CoV-2; SARS coronavirus 2 antibody titer; neutralizing antibodies; COVID-19; intravenous immunoglobulin; plasma; CORONAVIRUS; SERA;

D O I：

10.1093/infdis/jiaa593

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The 2020 SARS-CoV-2 pandemic is caused by a zoonotic coronavirus transmitted to humans, similar to earlier events. Whether the other, seasonally circulating coronaviruses induce cross-reactive, potentially even cross-neutralizing, antibodies to the new species in humans is unclear. The question is particularly relevant for people with immune deficiencies, as their health depends on treatment with immunoglobulin preparations that need to contain neutralizing antibodies against the pathogens in their environment. Testing 54 intravenous immunoglobulin preparations, produced from plasma collected in Europe and the United States, confirmed highly potent neutralization of a seasonal coronavirus; however, no cross-neutralization of the new SARS-CoV-2 was seen.

引用

页码：1960 / 1964

页数：5

共 50 条

[21] Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
Burnouf, Thierry
Gathof, Birgit
Bloch, Evan M.
Bazin, Renee
de Angelis, Vincenzo
Patidar, Gopal Kumar
Rastvorceva, Rada M. Grubovic
Oreh, Adaeze
Goel, Ruchika
Rahimi-Levene, Naomi
Hindawi, Salwa
Al-Riyami, Arwa Z.
So-Osman, Cynthia
TRANSFUSION MEDICINE REVIEWS, 2022, 36 (03) : 125 - 132
[22] SARS-CoV-2 and the pandemic of COVID-19
Adil, Md Tanveer
Rahman, Rumana
Whitelaw, Douglas
Jain, Vigyan
Al-Taan, Omer
Rashid, Farhan
Munasinghe, Aruna
Jambulingam, Periyathambi
POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1144) : 110 - 116
[23] Evolutionary medical insights into the SARS-CoV-2 pandemic
Crespi, Bernard
EVOLUTION MEDICINE AND PUBLIC HEALTH, 2020, (01) : 314 - 322
[24] The Impact of SARS-CoV-2 (COVID-19) Pandemic on International Dermatology Conferences in 2020
Ha, Eun Seo
Hong, Ji Yeon
Lim, Sophie Soyeon
Soyer, H. Peter
Mun, Je-Ho
FRONTIERS IN MEDICINE, 2021, 8
[25] Detection of microorganisms in hospital air before and during the SARS-CoV-2 pandemic
Zhao, Y-H
Qu, H.
Wang, Y.
Wang, R.
Zhao, Y.
Huang, M-X
Li, B.
Zhu, W-M
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (03) : 1020 - 1027
[26] A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
Donofrio, Gaetano
Franceschi, Valentina
Macchi, Francesca
Russo, Luca
Rocci, Anna
Marchica, Valentina
Costa, Federica
Giuliani, Nicola
Ferrari, Carlo
Missale, Gabriele
VACCINES, 2021, 9 (04)
[27] Letter to the editor regarding Supplement 1, 2020 on the SARS-CoV-2 pandemic
Loredo-Abdala, Arturo
Alejandro Galvan-Diaz, Cesar
Evelyn Aguilar-Gomez, Nancy
Krystel Cervantes-Perez, Linsay
Alfredo Ojeda-Perez, Pablo
Casas-Munoz, Abigail
ACTA PEDIATRICA DE MEXICO, 2020, 41 (05): : 235 - 239
[28] Comparison of Four SARS-CoV-2 Neutralization Assays
Riepler, Lydia
Roessler, Annika
Falch, Albert
Volland, Andre
Borena, Wegene
von Laer, Dorothee
Kimpel, Janine
VACCINES, 2021, 9 (01) : 1 - 14
[29] THE INCIDENCE OF PEDIATRIC EYE INJURIES - BEFORE AND DURING THE SARS-CoV-2 PANDEMIC
Andronic, Daniela Gabriela
Anton, Nicoleta
Niagu, Irina Andreea
Bogdanici, Camelia Margareta
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2021, 125 (04): : 521 - 530
[30] Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors
Carmen Martin, M.
Jimenez, Ana
Ortega, Nuria
Parrado, Alba
Page, Isabel
Isabel Gonzalez, M.
Blanco-Peris, Lydia
PLOS ONE, 2022, 17 (02):

← 1 2 3 4 5 →